Literature DB >> 19398439

A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

R J Rigby1, M R Hunt, B P Scull, J G Simmons, K E Speck, M A Helmrath, P K Lund.   

Abstract

OBJECTIVE: Ileocaecal resection (ICR) is common in Crohn's disease. Inflammation and fibrosis frequently recur at the site of anastomosis or in the small intestine (SI). No animal models of postsurgical inflammation and fibrosis exist. A model of ICR was developed in interleukin 10 (IL10) null and wild-type (WT) mice to test the hypothesis that ICR promotes postsurgical inflammation and fibrosis in the SI or anastomosis of genetically susceptible IL10 null, but not WT or germ-free (GF)-IL10 null mice.
METHODS: GF-IL10 null mice were conventionalised (CONV) and 3 weeks later randomised to ICR, transection (T) or no treatment (NoTx). Age-matched conventionally raised (CONV) WT and GF-IL10 null mice received ICR, T or NoTx. Animals were killed 28 days later. Histological scoring, real-time PCR for tumour necrosis factor alpha and collagen, and immunostaining for CD3(+) T cells assessed inflammation and fibrosis.
RESULTS: After ICR, CONV-IL10 null, but not CONV-WT mice, developed significant inflammation and fibrosis in the SI and inflammation in anastomosis compared with NoTx or T controls. Fibrosis occurred in the anastomosis of both CONV-IL10 null and CONV-WT mice following ICR. GF-IL10 null mice developed little or no inflammation or fibrosis in the SI or anastomosis after ICR.
CONCLUSIONS: ICR in CONV-IL10 null mice provides a new animal model of postsurgical inflammation and fibrosis in the SI and anastomosis. Absence of inflammation and fibrosis in the SI of CONV-WT and GF-IL10 null mice following ICR indicates that postsurgical small bowel disease occurs only in genetically susceptible IL10 null mice and is bacteria dependent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398439      PMCID: PMC2752281          DOI: 10.1136/gut.2008.157636

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  46 in total

1.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Authors:  M M Kosiewicz; C C Nast; A Krishnan; J Rivera-Nieves; C A Moskaluk; S Matsumoto; K Kozaiwa; F Cominelli
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Probiotics in the treatment of inflammatory bowel disease.

Authors:  Kevin P Rioux; Richard N Fedorak
Journal:  J Clin Gastroenterol       Date:  2006-03       Impact factor: 3.062

Review 3.  Treatment of inflammatory bowel disease with antibiotics.

Authors:  Kim L Isaacs; R Balfour Sartor
Journal:  Gastroenterol Clin North Am       Date:  2004-06       Impact factor: 3.806

Review 4.  Postoperative Crohn's disease.

Authors:  Robert M Penner; Karen L Madsen; Richard N Fedorak
Journal:  Inflamm Bowel Dis       Date:  2005-08       Impact factor: 5.325

5.  Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease.

Authors:  Dario Sorrentino; Claudio Avellini; Carlo Alberto Beltrami; Enrico Pasqual; Ester Zearo
Journal:  Int J Colorectal Dis       Date:  2005-06-11       Impact factor: 2.571

6.  Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts.

Authors:  E A van Tol; L Holt; F L Li; F M Kong; R Rippe; M Yamauchi; J Pucilowska; P K Lund; R B Sartor
Journal:  Am J Physiol       Date:  1999-07

7.  Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria.

Authors:  Sandra C Kim; Susan L Tonkonogy; Carol A Albright; Julia Tsang; Edward J Balish; Jonathon Braun; Mark M Huycke; R Balfour Sartor
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

8.  Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul Rutgeerts; Gert Van Assche; Séverine Vermeire; Geert D'Haens; Filip Baert; Maja Noman; Isolde Aerden; Gert De Hertogh; Karel Geboes; Martin Hiele; Andre D'Hoore; Freddy Penninckx
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

9.  Postoperative short bowel syndrome.

Authors:  Jon S Thompson; John K DiBaise; Kishore R Iyer; Melania Yeats; Debra L Sudan
Journal:  J Am Coll Surg       Date:  2005-07       Impact factor: 6.113

10.  Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice.

Authors:  Christopher M Dekaney; Jerry J Fong; Rachael J Rigby; P Kay Lund; Susan J Henning; Michael A Helmrath
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-13       Impact factor: 4.052

View more
  20 in total

Review 1.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

Review 2.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

3.  Murine ileocolic bowel resection with primary anastomosis.

Authors:  Troy Perry; Anna Borowiec; Bryan Dicken; Richard Fedorak; Karen Madsen
Journal:  J Vis Exp       Date:  2014-10-29       Impact factor: 1.355

4.  SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis.

Authors:  Keith W McLarren; Alexandra E Cole; Shelley B Weisser; Nicole S Voglmaier; Victoria S Conlin; Kevan Jacobson; Oana Popescu; Jean-Luc Boucher; Laura M Sly
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  Themes in fibrosis and gastrointestinal inflammation.

Authors:  Claudio Fiocchi; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-17       Impact factor: 4.052

6.  Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice.

Authors:  Chen-Zhang Shi; Hong-Qi Chen; Yong Liang; Yang Xia; Yong-Zhi Yang; Jun Yang; Jun-Dong Zhang; Shu-Hai Wang; Jing Liu; Huan-Long Qin
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 7.  Prevention of post-operative recurrence of Crohn's disease.

Authors:  Byron Philip Vaughn; Alan Colm Moss
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

8.  Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis.

Authors:  Rachael J Rigby; Jacquelyn Carr; Kelly Orgel; Stephanie L King; P Kay Lund; Christopher M Dekaney
Journal:  Gut Microbes       Date:  2016-07-26

9.  Tis7 deletion reduces survival and induces intestinal anastomotic inflammation and obstruction in high-fat diet-fed mice with short bowel syndrome.

Authors:  Amy M Garcia; Derek Wakeman; Jianyun Lu; Christopher Rowley; Taylor Geisman; Catherine Butler; Shashi Bala; Elzbieta A Swietlicki; Brad W Warner; Marc S Levin; Deborah C Rubin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

10.  Inflammation enhances resection-induced intestinal adaptive growth in IL-10 null mice.

Authors:  Karen E Speck; Aaron P Garrison; Rachael J Rigby; Doug C von Allmen; P Kay Lund; Michael A Helmrath
Journal:  J Surg Res       Date:  2009-10-22       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.